drugset / Trial / NCT00644709

A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)

NCT00644709 ↗

Phase 4 Completed 196 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A study of the long-term (1 year) effectiveness of atorvastatin to keep patients of high cardiovascular risk at the LDL cholesterol goal of \<115 mg/dL

Timeline

Start
2003-09
Primary completion
—
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —
Subject Atorvastatin Small molecule 20 mg —
Subject Atorvastatin Small molecule 40 mg —
Subject Atorvastatin Small molecule 80 mg —

Indications